Literature DB >> 19276765

Inhibition of Janus kinase 2 and signal transduction and activator of transcription 3 protect against cecal ligation and puncture-induced multiple organ damage and mortality.

Liu Hui1, Yongming Yao, Songbai Wang, Yan Yu, Ning Dong, Hongyun Li, Zhiyong Sheng.   

Abstract

BACKGROUND: Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway plays an important role in sepsis, transducing a multitude of inflammatory signals. To date, knowledge of JAK/STAT pathway in sepsis is limited. This study was to investigate the potential role of JAK/STAT pathway in mediating multiple organ damage and mortality in septic rats. Our data showed that inhibition of JAK2/STAT3 attenuated cecal ligation and puncture-induced multiple organ damage and mortality in 48 hours in rats.
METHODS: A total of 98 male Wistar rats were randomly divided into 4 groups as follows: (1) normal control group (n = 10); (2) cecal ligation and puncture (CLP) group (n = 40), which was further divided into 2, 6, 24, 48-hour post-CLP groups; (3) AG490 (8.0 mg/kg, Calbiochem, La Jolla, CA) treatment group (n = 24), which was further divided into 2, 6, 24, 48-hour post-CLP groups; (4) rapamycin (0.4 mg/kg, Calbiochem, Calbiochem, La Jolla, CA) treatment group (n = 24), which was further divided into 2, 6, 24, 48-hour post-CLP groups; CLP was performed to induce experimental sepsis. AG490 (8 mg/kg) or rapamycin (0.4 mg/kg) was injected subcutaneously 0.5 hour before CLP in respective group. Animals were killed at destined time after CLP (not including the death rate observation group), and specimens of serum, liver, and lungs were harvested and stored in liquid nitrogen for subsequent analyses. In an additional experiment, 88 animals were randomly divided into three groups to compare the survival rate, including CLP group (n = 40), AG490 treatment group (8 mg/kg, n = 24), and rapamycin treatment group (0.4 mg/kg, n = 24). Mortality of rats in each group was recorded up to 48 hours after the procedure.
RESULTS: After CLP challenge, myeloperoxidase (MPO), aspartate transaminase, and alanine aminotransferase levels, as well as activation of JAK2 and STAT3, were markedly increased. Administration of AG490 or rapamycin significantly decreased activation of JAK2 and STAT3, as well as high mobility group box-1 protein, MPO, alanine aminotransferase levels (p < 0.05 or p < 0.01). In addition, treatment with AG490 or rapamycin significantly improved the 48-hour survival rate from 37.5% (15 of 40) to 66.7% (16 of 24) and 70.8% (17 of 24), respectively (both p < 0.05).
CONCLUSION: JAK2/STAT3 pathway might play a role in the development of multiple organ damage in septic rats, which suggested a potential strategy to control sepsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276765     DOI: 10.1097/TA.0b013e318164d05f

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  15 in total

1.  JAK2 inhibition prevents innate immune responses and rescues animals from sepsis.

Authors:  Geber Peña; Bolin Cai; Edwin A Deitch; Luis Ulloa
Journal:  J Mol Med (Berl)       Date:  2010-08       Impact factor: 4.599

2.  Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice.

Authors:  Hongfang Feng; Jiajia Chen; Haitao Wang; Yufang Cheng; Zhengqiang Zou; Qiuping Zhong; Jiangping Xu
Journal:  Lab Invest       Date:  2017-06-26       Impact factor: 5.662

Review 3.  The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.

Authors:  Bin Cai; Jian-ping Cai; Yu-long Luo; Cheng Chen; Sen Zhang
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

5.  [Electroacupuncture protects septic rats from acute lung injury through the JAK1/STAT3 pathway].

Authors:  Cancan Xie; Shuanghua Wu; Zhengrong Li; Bing Huang; Weizhong Zeng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

6.  Clinical and prognostic significance of high-mobility group box-1 in human gliomas.

Authors:  Xin-Jun Wang; Shao-Long Zhou; Xu-Dong Fu; Yan-Yan Zhang; Bo Liang; Ji-Xin Shou; Jian-Ye Wang; Jian Ma
Journal:  Exp Ther Med       Date:  2014-11-25       Impact factor: 2.447

7.  Expression of genes belonging to the interacting TLR cascades, NADPH-oxidase and mitochondrial oxidative phosphorylation in septic patients.

Authors:  Laura A Nucci; Sidnéia S Santos; Milena K C Brunialti; Narendra Kumar Sharma; Flavia R Machado; Murillo Assunção; Luciano C P de Azevedo; Reinaldo Salomao
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

Review 8.  Paradoxical Role of High Mobility Group Box 1 in Glioma: A Suppressor or a Promoter?

Authors:  Richard A Seidu; Min Wu; Zhaoliang Su; Huaxi Xu
Journal:  Oncol Rev       Date:  2017-03-03

9.  Phospho-Tyr705 of STAT3 is a therapeutic target for sepsis through regulating inflammation and coagulation.

Authors:  Shunyao Xu; Xiaojun Pan; Lingjie Mao; Hao Pan; Wenwei Xu; Yufeng Hu; Xueshu Yu; Zhiqiang Chen; Songzan Qian; Yincai Ye; Yueyue Huang; Jingye Pan
Journal:  Cell Commun Signal       Date:  2020-07-08       Impact factor: 5.712

10.  Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting α7 nAChR and M4 mAChR and inhibiting JAK2/STAT3 pathway in rats.

Authors:  Weiwei Zhang; Qi Sun; Xiaoli Gao; Yimin Jiang; Runtao Li; Jia Ye
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.